19 reports

  • SUMMARIZES THE KEY HISTORICAL AND PROJECTED PATENT EXPIRY DATES FOR MALARIA ACROSS THE 6MM.
  • 6.4 DRUG THERAPY PROCUREMENT

GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS, AND MALARIA (GFATM) (2018) THE GLOBAL FUND.

  • Malaria
  • Africa
  • World
  • Forecast
  • Novartis AG
  • 4.1 BIBLIOGRAPHY

PLoS One; ##(##): e##.

  • Malaria
  • Nigeria
  • World
  • Demographic
  • Forecast
  • Oct 31, 2017: GHIT Fund Accelerates Promising Efforts to Find New Treatments, Vaccines and Diagnostics for Malaria, Tuberculosis, Leishmaniasis and Mycetoma
  • Other Significant Developments

GHIT will continue to invest in the development of a new medicine to combat tuberculosis.

  • Malaria
  • United Kingdom
  • United States
  • World
  • Wellcome Trust
  • SMALL MOLECULES TO INHIBIT HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE
  • SMALL MOLECULES TO INHIBIT DXR FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE

DXR AND MEP ARE ESSENTIAL FOR MALARIA PARASITES AND TUBERCULOSIS BACTERIA TO SURVIVE.

  • Antimalarials
  • Malaria
  • Research And Development
  • United States
  • Sanaria Inc.
  • Oct 31, 2017: GHIT Fund Accelerates Promising Efforts to Find New Treatments, Vaccines and Diagnostics for Malaria, Tuberculosis, Leishmaniasis and Mycetoma

The company will issue the shares at an subscription ratio of ##:##.

  • Malaria
  • Pharmaceutical
  • United States
  • Company
  • MOLOGEN AG
  • SMALL MOLECULES TO INHIBIT DXR FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE
  • SMALL MOLECULES TO INHIBIT HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE

SMALL MOLECULES TO INHIBIT DXR FOR MALARIA AND TUBERCULOSIS - DRUG PROFILE SMALL MOLECULES TO INHIBIT DXR FOR MALARIA AND TUBERCULOSIS GEORGE WASHINGTON UNIVERSITY Mechanism Of Action R& D Progress SMALL MOLECULES ARE UNDER INVESTIGATION FOR THE TREATMENT OF MALARIA AND

  • Immunotherapy
  • Malaria
  • Vaccine
  • United States
  • Sanaria Inc.
  • Medicines for Malaria Venture, Key Competitors
  • Medicines for Malaria Venture Enters into Agreement with Cipla and Strides Arcolab

The company' s products find applications in the treatment of diseases such as AIDS, malaria and tuberculosis.

  • Malaria
  • Pharmaceutical
  • Switzerland
  • Company Operations
  • Eisai Co., Ltd.
  • APR 02, 2018: UNC RELEASES HUGE DATABASE OF MOLECULES TO SUPPORT ARTIFICIAL INTELLIGENCE METHODS IN CHEMISTRY

Investment in Tuberculosis Countering the Rise of Drug-resistant Tuberculosis The data and analysis within this report is driven by GlobalData.

  • Malaria
  • Pharmaceutical
  • Therapy
  • United States
  • Audentes Therapeutics, Inc.

Tuberculosis is one of the three most prevalent infectious diseases in the world.

  • Diagnostics
  • Genetic Testing
  • Malaria
  • Tuberculosis
  • Eiken Chemical Co., Ltd.
  • DESIGNMEDIX ENTERS INTO AGREEMENT WITH THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

The institute' s research areas include infectious diseases such as tuberculosis and influenza, HIV/ AIDS, biodefense; and immune-mediated diseases including asthma and allergy.

  • Healthcare
  • Malaria
  • United States
  • Deals & Alliance
  • DesignMedix
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Malaria
  • Therapy
  • World
  • GlaxoSmithKline plc

These include tuberculosis, one of the top ten causes of death worldwide, infecting ##. ## million and killing ##. ## million people in 2016 alone, and gonorrhoea, the sexually transmitted disease that infects ## million people a year and is now becoming extremely difficult to treat.

  • Genomics
  • Malaria
  • United Kingdom
  • World
  • Thermo Fisher Scientific, Inc.
  • FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS, MAJOR PRODUCTS AND SERVICES

FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions.

  • Malaria
  • Africa
  • India
  • Switzerland
  • Product Initiative
  • MALARIA - PIPELINE BY MICROBIOTIX INC
  • MALARIA - PIPELINE BY RODOS BIOTARGET GMBH

Its gene vaccines are used for the treatment of tuberculosis, influenza, malaria, Alzheimer' s disease, tumor and Parkinson' s disease, among others.

  • Infectious Disease
  • Malaria
  • Vaccine
  • Company
  • Product Initiative
  • Eisai Co., Ltd. - Discovery, 2016

Small Molecules for Tuberculosis Product Description Mechanism of Action Drug candidates are under development for tuberculosis.

  • Cancer
  • Malaria
  • Research And Development
  • Therapy
  • Eisai Co., Ltd.
  • THROMBOSIS
  • ASTRAZENECA PLC - DISCOVERY, 2016

The scientists reported ##, ##-azaindoles as a new inhibitor class that killed Mycobacterium tuberculosis in vitro and demonstrated efficacy in mouse tuberculosis models.

  • Blood Disease
  • Malaria
  • Therapy
  • United States
  • AstraZeneca PLC
  • INFECTION DETECTION TEST - P. FALCIPARUM - PRODUCT DESCRIPTION
  • INFECTION DETECTION TEST - P. FALCIPARUM - PRODUCT STATUS

FIND also provides malaria therapy programs, neglected tropical diseases therapy programs, tuberculosis therapy programs, HIV therapy programs, and cross-cutting themes solutions.

  • Malaria
  • Pharmaceutical
  • United States
  • Company
  • Micronics, Inc.
  • Cellceutix Corporation - Dormant Developmental Projects,2016

It is a defensin mimetic anti-tuberculosis compound.

  • Malaria
  • Research And Development
  • United States
  • Company Operations
  • Cellceutix Corporation
  • Official Title
  • Clinical Trial Profile Snapshots

The prominent features of this report are - ##.

  • Clinical Trial
  • Infectious Disease
  • Malaria
  • Pharmaceutical
  • World